M. Robert Cooper
Wake Forest University Health Sciences · 191 works · 10,329 citations · h-index 45
Top works
- Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
- Daunorubicin in the therapy of acute granulocytic leukemia.
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVD
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer
- Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas
- Familial protein S deficiency is associated with recurrent thrombosis.
- Written informed consent in patients with breast cancer
- A modified procedure for the determination of loukocyte alkaline phosphatase
- Complete Deficiency of Leukocyte Glucose-6-Phosphate Dehydrogenase with Defective Bactericidal Activity
- Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.
- Interrupted versus Continuous Chemotherapy in Patients with Metastatic Breast Cancer
- Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.
- A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer
- Alemtuzumab in Previously Treated Chronic Lymphocytic Leukemia Patients Who Also Had Received Fludarabine
- Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer. A randomized trial
- Hodgkin disease survivors at increased risk for problems in psychosocial adaptation
- Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
- High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
- Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. The Cancer and Leukemia Group B.
- Nitroblue Tetrazolium Reduction: False Positive and False Negative Results